Novartis Ag (NVSEF) Gross Margin (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) Gross Margin (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -154.31 Mn
Mar 31, 2023 193.69 Mn
Dec 31, 2022 -81.74 Mn
Sep 30, 2022 42.37 Mn
Jun 30, 2022 5,980.00
Mar 31, 2022 1,317.00
Dec 31, 2021 -924.00
Sep 30, 2021 929.00
Jun 30, 2021 -498.00
Mar 31, 2021 -617.00
Dec 31, 2020 -756.30 Mn
Sep 30, 2020 756.30 Mn
Jun 30, 2020 -185.00
Jun 30, 2019 6,432.00
Mar 31, 2019 -37,659.00
Dec 31, 2018 17,023.00
Sep 30, 2018 14,708.00
Jun 30, 2018 6,066.00
Mar 31, 2018 -39,839.00
Dec 31, 2017 -2,687.00